Close Menu

NEW YORK (GenomeWeb) – Non-profit fundraising organization Stand Up to Cancer (SU2C) announced today the launch of four research projects that will use genetic and other technologies to detect and treat cancer at its earliest stages.

The projects are part of the SU2C Cancer Interception initiative and will specifically focus on lung and pancreatic cancer. They will be be funded with a total of $16.6 million provided by SU2C, the Lustgarten Foundation for Pancreatic Cancer Research, LUNGevity, and the American Lung Association.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Jun
04
Sponsored by
Ovation

This webinar will discuss the current status of COVID-19 testing, treatment and other aspects of the current pandemic as they relate to getting this outbreak under control.